Theories of endometrial carcinogenesis: a multidisciplinary approach (Q33886758)

29 July 2017

1 reference

title

Theories of endometrial carcinogenesis: a multidisciplinary approach (English)

1 reference

29 July 2017

1 reference

Sherman ME

1

1 reference

29 July 2017

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

13

1 reference

29 July 2017

295-308

1 reference

29 July 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3880051

29 July 2017

0 references

cites work

p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Two pathogenetic types of endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

21 January 2018

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Relationship between race and interval to treatment in endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Case-control study of endogenous steroid hormones and endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma: precursor of uterine papillary serous carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

p53 expression in neoplasms of the uterine corpus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Expression and mutation analysis of the p53 gene in uterine papillary serous carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Uterine papillary serous carcinoma evolves via a p53-driven pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Microsatellite instability in sporadic endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Analysis of oncogene alterations in human endometrial carcinoma: prevalence of ras mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Mutations of the Ki-ras oncogene in endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Biochemical and immunohistochemical estrogen and progesterone receptors in adenomatous hyperplasia and endometrial carcinoma: correlations with stage and other clinicopathologic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Stromal estrogen receptors mediate mitogenic effects of estradiol on uterine epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Molecular mechanisms of estrogen carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Carcinosarcoma (malignant mixed müllerian (mesodermal) tumor) of the female genital tract: immunohistochemical and ultrastructural analysis of 28 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Characteristics of cloned cells of mixed müllerian tumor of the human uterus. Carcinoma cells showing myogenic differentiation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Establishment and characterization of carcinosarcoma cell line of the human uterus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

Endometrial cancer: stage at diagnosis and associated factors in black and white patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

7 January 2021

Sonographic visualization of the ovaries throughout pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

7 January 2021

Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

7 January 2021

Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

7 January 2021

Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Report of seven cases and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

7 January 2021

Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

7 January 2021

Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

7 January 2021

Endometrial carcinoma in situ in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

7 January 2021

Uterine papillary serous carcinoma: patterns of metastatic spread

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

7 January 2021

Correlations between p21 expression and clinicopathological findings, p53 gene and protein alterations, and survival in patients with endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

7 January 2021

Distinctive p53 and mdm2 immunohistochemical expression profiles suggest different pathogenetic pathways in poorly differentiated endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

7 January 2021

Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

7 January 2021

The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880051

7 January 2021

10.1038/MODPATHOL.3880051

Identifiers

DOI

1 reference

PubMed ID

10757340

Dimensions Publication ID

29 July 2017

0 references

1 reference

PubMed ID

10757340